✦ LIBER ✦

From drug discovery to biomarker-driven clinical trials in lymphoma

✍ Scribed by Younes, Anas; Berry, Donald A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toxicogenomics in drug discovery: from p

✍ Yi Yang; Eric A.G. Blomme; Jeffrey F. Waring 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 432 KB

From Darkness to Light With Biomarkers i

✍ Carden, CP; Banerji, U; Kaye, SB; Workman, P; de Bono, JS 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 122 KB

Biomarkers: hopes and challenges in the

✍ Nikolaos G. Frangogiannis 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Clinical Proteomics (From Diagnosis to T

✍ Van Eyk, Jennifer E.; Dunn, Michael J. 📂 Article 📅 2008 🏛 Wiley-VCH Verlag GmbH & Co. KGaA ⚖ 210 KB

Innovation and greater probability of su

✍ Ismail Kola; Daria Hazuda 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Pitfalls and limitations in translation

✍ Elisabeth Drucker, Kurt Krapfenbauer 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 284 KB